Methcathinone: Difference between revisions
CSV import |
CSV import |
||
| Line 31: | Line 31: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Methcathinone skeletal.svg|Methcathinone skeletal structure | |||
File:Methcathinone molecule ball.png|Methcathinone molecule ball model | |||
</gallery> | |||
Latest revision as of 01:21, 20 February 2025
'Methcathinone (also known as ephedrone, monoamine alkaloids, Jeff, mulka, cat, wild cat, bathtub speed, and goob) is a psychoactive drug that is similar to amphetamine in its effects. It is a stimulant and entactogen drug of the phenethylamine, amphetamine, and cathinone chemical classes. It is known to be addictive and is illegal in many countries.
History[edit]
Methcathinone was first synthesized in 1928 in the United States and was patented by Parke Davis in 1957. It was used in the Soviet Union during the 1930s and 1940s as an anti-depressant. Methcathinone has long been used as a drug of abuse in the Soviet Union and Russia.
Chemistry[edit]
Methcathinone is a keto derivative of ephedrine. It is often synthesized from ephedrine or pseudoephedrine. The synthesis of methcathinone involves oxidation of ephedrine or pseudoephedrine. The most common method of synthesis is by the oxidation of ephedrine with chromium (VI) oxide.
Effects[edit]
The effects of methcathinone are similar to those of amphetamine, although it is less potent and has a shorter duration. The effects include euphoria, increased heart rate, increased blood pressure, dilated pupils, and increased body temperature. Methcathinone can also cause hallucinations, paranoia, and aggressive behavior.
Health risks[edit]
The use of methcathinone can lead to a number of health risks. These include heart problems, stroke, and damage to the brain and other organs. Long-term use can lead to addiction, mental health problems, and severe physical health problems.
Legal status[edit]
Methcathinone is illegal in many countries, including the United States, Canada, Australia, and many European countries. In the United States, it is classified as a Schedule I drug under the Controlled Substances Act.
